Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 18;13(12):3567.
doi: 10.3390/jcm13123567.

New Pharmacological Therapies in the Treatment of Epilepsy in the Pediatric Population

Karolina Daniłowska  1 , Natalia Picheta  1 , Dominika Żyła  1 , Julia Piekarz  1 , Katarzyna Zych  1 , Paulina Gil-Kulik  2
Affiliations
Review

New Pharmacological Therapies in the Treatment of Epilepsy in the Pediatric Population

Karolina Daniłowska et al. J Clin Med. .

Abstract

Epilepsy is a disorder characterized by abnormal brain neuron activity, predisposing individuals to seizures. The International League Against Epilepsy (ILAE) categorizes epilepsy into the following groups: focal, generalized, generalized and focal, and unknown. Infants are the most vulnerable pediatric group to the condition, with the cause of epilepsy development being attributed to congenital brain developmental defects, white matter damage, intraventricular hemorrhage, perinatal hypoxic-ischemic injury, perinatal stroke, or genetic factors such as mutations in the Sodium Channel Protein Type 1 Subunit Alpha (SCN1A) gene. Due to the risks associated with this condition, we have investigated how the latest pharmacological treatments for epilepsy in children impact the reduction or complete elimination of seizures. We reviewed literature from 2018 to 2024, focusing on the age group from 1 month to 18 years old, with some studies including this age group as well as older individuals. The significance of this review is to present and compile research findings on the latest antiseizure drugs (ASDs), their effectiveness, dosing, and adverse effects in the pediatric population, which can contribute to selecting the best drug for a particular patient. The medications described in this review have shown significant efficacy and safety in the studied patient group, outweighing the observed adverse effects. The main aim of this review is to provide a comprehensive summary of the current state of knowledge regarding the newest pharmacotherapy for childhood epilepsy.

Keywords: antiseizure drugs; epilepsy in children; pediatric epilepsy; pharmacological treatment; seizure control.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Fisher R.S., Boas W.V.E., Blume W., Elger C., Genton P., Lee P., Engel J. Epileptic Seizures and Epilepsy: Definitions Proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE) Epilepsia. 2005;46:470–472. doi: 10.1111/j.0013-9580.2005.66104.x. - DOI - PubMed
    1. [(accessed on 29 April 2024)]. Available online: https://epilepsydiagnosis.org.
    1. Auvin S. Paediatric epilepsy and cognition. Dev. Med. Child Neurol. 2022;64:1444–1452. doi: 10.1111/dmcn.15337. - DOI - PubMed
    1. Bajaj J., Soni P., Khandelwal N., Hedaoo K., Kumar A., Sinha M., Ratre S., Parihar V., Swamy M.N., Yadav Y.R. Epilepsy-Related Injuries in Children: An Institution-Based Study. Neurol. India. 2022;70:1091. doi: 10.4103/0028-3886.349663. - DOI - PubMed
    1. Ioannou P., Foster D.L., Sander J.W., Dupont S., Gil-Nagel A., Drogon O’Flaherty E., Alvarez-Baron E., Medjedovic J. The burden of epilepsy and unmet need in people with focal seizures. Brain Behav. 2022;12:e2589. doi: 10.1002/brb3.2589. - DOI - PMC - PubMed

LinkOut - more resources